An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
It is generally believed that treatments are available to manage irritability in Huntington's disease (HD). However, lack of an evidence base prevents the establishment of treatment guidelines for this symptom. The research literature fails to address behavioral intervention strategies, drug selection, drug dosing, management of inadequate response to a single drug, or preferred drugs when additional behavioral symptoms comorbid to irritability are present. In an effort to inform clinical decision-making we surveyed an international group of experts to address these points. The experts consistently endorsed an antipsychotic drug (APD) as first choice for treatment of urgent and aggressive irritability behaviors. However, there was variation in practice patterns for treating less severe symptoms. Serotonin reuptake inhibitors (SSRIs) were first choice drug treatments by most respondents across all geographic regions. However, APDs were also endorsed as first choice for mild or moderate irritability, more frequently in Europe than in North America and Australia. Antiepileptic mood stabilizers (AEDs) were used by fewer respondents as first choice drug. Perceived efficacy for control of mild or moderate irritability was judged somewhat higher for APDs than SSRIs or AEDs. Benzodiazepines were not used as monotherapy, but frequently as an adjunctive drug in the setting of comorbid anxiety. Though many cited lack of experience with mirtazapine, others familiar with its use in HD chose it as an alternative monotherapy, or as adjunctive therapy if insomnia was a comorbid factor. This report presents survey results, reviews available irritability studies, and lastly proposes an algorithm for the treatment of irritability in HD derived from expert preferences obtained through this survey.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropsychiatric aspects of Huntington’s disease.
Paulsen, J. S. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.3.310 · Cited by 486 · cited 1×
“Estimates of irritability vary from 31% to 65% according to studies using different methods of sampling and measurement [4] [5].”
Einstellung der Bevölkerung zu Alkoholkranken
Schomerus, G., Holzinger, A., Matschinger, H., Lucht, M., & Angermeyer, M. (2010) · Psychiatrische Praxis · doi:10.1055/s-0029-1223438 · Cited by 55
Cited by
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
Therapeutic Advances for Huntington’s Disease
Kumar, A., Kumar, V., Singh, K., Kumar, S., Kim, Y.-S., Lee, Y.-M., & Kim, J.-J. (2020) · Brain Sciences · doi:10.3390/brainsci10010043 · Cited by 164
Anderson, K. E., van Duijn, E., Craufurd, D., Drazinic, C., Edmondson, M., Goodman, N., van Kammen, D., Loy, C., Priller, J., & Goodman, L. V. (2018) · Journal of Huntington's Disease · doi:10.3233/jhd-180293 · Cited by 108
“We have previously published opinion-based algorithms for the clinical management of chorea [15], irritability [16] and obsessive-compulsive or perseverative behaviors [17].”
MethodSelf-citationThorley, E. M., Iyer, R. G., Wicks, P., Curran, C., Gandhi, S. K., Abler, V., Anderson, K. E., & Carlozzi, N. E. (2018) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-018-0312-x · Cited by 32
Self-citation
Metadata
- Authors
- Groves, M., van Duijn, E., Anderson, K., Craufurd, D., Edmondson, M. C., Goodman, N., van Kammen, D. P., & Goodman, L.
- Venue
- PLoS Currents
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-30
- Volume
- 3
- Pages
- RRN1259
- ISSN
- 2157-3999 (ISSN-L)
- OpenAlex
- W1967798888
- Cited by
- 102
- References
- 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease. https://app.cochat.ai/papers/10.1371/currents.rrn1259
- The paper
- Groves, M., van Duijn, E., Anderson, K., Craufurd, D., Edmondson, M. C., Goodman, N., van Kammen, D. P., & Goodman, L. (2011). An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease. PLoS Currents. https://doi.org/10.1371/currents.rrn1259
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.